Cytomorphological analysis of liquid platelet-rich fibrin produced with the DUO fixed angle centrifuge (Process, France) for use in the regenerative therapy of skin ulcers

Submitted: June 3, 2023
Accepted: October 16, 2023
Published: December 14, 2023
Abstract Views: 159
PDF: 43
Supplementary Materials: 14
PDF (Italiano): 68
Materiali Supplementari (Italiano): 18
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Liquid platelet-rich fibrin (PRF) is an injectable second-generation platelet concentrate rich in platelets, leukocytes and fibrinogen obtained by centrifugation of autologous blood. The aim of this study is to analyze the cellular and Fibrinogen content of various types of liquid PRF (C-PRF liquid, A-PRF liquid, i-PRF, liquid fibrinogen) obtained with the use of DUO Fixed Angle Centrifuge (PRF DUO, Process for PRF, Nice, France) with Vacumed liquid fibrinogen (LF) tubes (code 44909) and/or Original S-PRF Sticky tube. An average accumulation of thrombocytes of almost 1.5 times compared to whole blood was found. Due to the high concentration of platelets, PRF-liquids contain important growth factors for tissue regeneration. In this preliminary study we highlighted that the type of liquid PRF has a higher content of platelets (126.3% vs. 109.5%), monocytes (127.6% vs. 84.6%), with a sufficient content of lymphocytes (192.9% vs. 242.1%) and neutrophil granulocytes (64.6% vs. 64.8%) and fibrinogen (67.9% vs. 87.3%), is the i-PRF (700 rpm×5 min) obtained with Vacumed LF tube (code 44909) with statistically insignificant differences compared to whole blood, while the content of Lymphocytes and Fibrinogen present in i-PRF (700 rpm×5’) obtained with PRF-S-Sticky tube is higher. In comparison, the content of cells and fibrinogen obtained with the two methods of preparing platelet-rich plasma is much lower. This indicates that the liquid PRF is most suitable to be used in various cases of tissue regeneration such as facial aesthetics, intra-articular injection, periulcerative injection, etc. is the i-PRF (700 rpm×5 min) obtained with a Vacumed LF tube.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Shao Z, Lyu C, Teng L, et al. An Injectable Fibrin Scaffold Rich in Growth Factors for Skin Repair. Biomed Res Int 2021:8094932. DOI: https://doi.org/10.1155/2021/8094932
Singh D, Rai V, Agrawal DK. Regulation of Collagen I and Collagen III in Tissue Injury and Regeneration. Cardiol Cardiovasc Med 2023;7:5-16. DOI: https://doi.org/10.26502/fccm.92920302
Crisci A, Crisci M. Second-Generation Platelet Concentrates (PRFs): Estimation of Cellular Content. Biointerface Res Appl Chem 2022;12:4747-54, DOI: https://doi.org/10.33263/BRIAC124.47474754
Crisci A, De Crescenzo U, Crisci M. Platelet-Rich Concentrates (L-PRF, PRP) in Tissue Regeneration: Control of Apoptosis and Interactions with Regenerative Cells. J Clin Mol Med 2018;1:5-2. DOI: https://doi.org/10.15761/JCMM.1000116
Karimi K, Rockwell H. The Benefits of Platelet-Rich Fibrin. Facial Plast Surg Clin North Am 2019;27:331-40. DOI: https://doi.org/10.1016/j.fsc.2019.03.005
Castro AB, Andrade C, Li X, et al. Impact of g force and timing on the characteristics of platelet-rich fibrin matrices. Sci Rep 2021;11:6038. DOI: https://doi.org/10.1038/s41598-021-85736-y
Rattanasuwan K, Rassameemasmaung S, Kiattavorncharoen S, et al. Platelet-rich plasma stimulated proliferation, migration, and attachment of cultured periodontal ligament cells. Eur J Dent 2018;11:192-5. DOI: https://doi.org/10.4103/ejd.ejd_255_17
Miron R, Chai J, Zhang P, et al., A novel method for harvesting concentrated platelet-rich fibrin (C-PRF) with a 10-fold increase in platelet and leukocyte yields. Clin Oral Investig 2020;24:2819-28. DOI: https://doi.org/10.1007/s00784-019-03147-w
Kargarpour Z, Panahipour L, Miron RJ, Gruber R. Fibrinogen Concentrations in Liquid PRF Using Various Centrifugation Protocols. Molecules 2022;27:2043. DOI: https://doi.org/10.3390/molecules27072043
O'Connell SM. Safety issues associated with platelet-rich fibrin method. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:587-93. DOI: https://doi.org/10.1016/j.tripleo.2007.03.017
Crisci A, Barillaro MC, Lepore G, Cardillo F. L-PRF Membrane (Fibrin Rich in Platelets and Leukocytes) and Its Derivatives (A-PRF, i-PRF) are Helpful as a Basis of Stem Cells in Regenerative Injury Treatment: Trial Work on the Horse. Int Blood Res Rev 2020;10:1-14. DOI: https://doi.org/10.9734/ibrr/2019/v10i230117
Pietruszka P, Chruścicka I, Duś-Ilnicka I, Paradowska-Stolarz A. PRP and PRF-Subgroups and Divisions When Used in Dentistry. J Pers Med 2021;11:944. DOI: https://doi.org/10.3390/jpm11100944
Zwittnig K, Kirnbauer B, Jakse N, et al. Growth Factor Release within Liquid and Solid PRF. J. Clin. Med 2022;11:5070. DOI: https://doi.org/10.3390/jcm11175070
Bucalossi M, Mariani F. Mononucleate da sangue periferico autologhe da filtrazione selettiva per il trattamento delle lesioni croniche dell'arto inferiore. Risultati a 4 anni. Ital J Wound Care 2021;5. DOI: https://doi.org/10.4081/ijwc.2021.69
Jaipersad A, Lip G, Silverman S, et al. The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol 2014;63:1-11. DOI: https://doi.org/10.1016/j.jacc.2013.09.019
Lopes-Coelho F, Silva F, Gouveia-Fernandes S, et al. Monocytes as Endothelial Progenitor Cells (EPCs), Another Brick in the Wall to Disentangle Tumor Angiogenesis. Cells 2020;9:107. DOI: https://doi.org/10.3390/cells9010107
Serafini G, Lopreiato M, Lollobrigida M, et al. Platelet rich fibrin (PRF) and its related products: biomolecular characterization of the liquid fibrinogen. J Clin Med 2020;9:1099. DOI: https://doi.org/10.3390/jcm9041099
Przadka P, Kiełbowicz Z, Skrzypczak P. Autogenne osocze bogatopłytkowe—Rodzaje, sposoby aktywacji i zastosowanie. Med Weter 2016;72:403-7. DOI: https://doi.org/10.21521/mw.5539
De Almeida Barros Mourrao CF, Valiense H, Melo ER, et al. Obtention of injectable platelets rich-fibrin (i-PRF) and its polymerization with bone graft: tecnical note. Rev Col Bras Cir 2015;42:421-3. DOI: https://doi.org/10.1590/0100-69912015006013
Sneha K, Rani AJ, Chandra RV, et al. The G‑force conundrum in platelet‑rich fibrin generation: Management of a problem hidden in plain sight. Contemp Clin Dent 2022;13:150-5. DOI: https://doi.org/10.4103/ccd.ccd_830_20
Pavlovic V, Ciric M, Jovanovic V, et al. Platelet-rich fibrin: Basics of biological actions and protocol modifications. Open Med (Wars) 2021;16:446-54. DOI: https://doi.org/10.1515/med-2021-0259
Handagama P, Scarborough RM, Shuman MA, Bainton DF. Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa). Blood 1993;82:135-8. DOI: https://doi.org/10.1182/blood.V82.1.135.bloodjournal821135
Ragunanthan N, Anchana Devi C, Hemavani V. A novel approach of harvesting concentrated plasma-rich fibrin (PRF) with increased platelet count. J Med Res Innov 2022;6:1-8.
Castro AB, Cortellini S, Temmerman A, et al. Characterization of the Leukocyte- and Platelet-Rich Fibrin Block: Release of Growth Factors, Cellular Content, and Structure. Int J Oral Maxillofac Implants 2019;34:855-64. DOI: https://doi.org/10.11607/jomi.7275
Crisci A, Benincasa G, Crisci M, Crisci F. Leukocyte Platelet-Rich Fibrin (L-PRF), a new biomembrane useful in tissue repair: basic science and literature review. Biointerface Res Appl Chem 2018;8:3635-43.
Crisci A, Kawase T, D’Adamo R, Crisci M. Experimental research on a technique for quantification of platelets and leukocytes in second-generation platelet concentrates. Int J Curr Med Pharma Res 2019;5:4792-9.
Crisci A, Crisci M, Flagiello F. Second generation solid platelet concentrates (L-PRF, A-PRF): morphometric characteristics. Experimental research on the horse. Ame J Eng Res (AJER) 2022;11:107-17.
Crisci M, Crisci A. Estimation of Cellular Content in Second-Generation Solid Fibrin Concentrates (PRFs). Cutting Edge Res Biol 2023;4:52-64. DOI: https://doi.org/10.9734/bpi/cerb/v4/17885D
Husakova J, Bem R, Fejfarova V, et al. Factors Influencing the Risk of Major Amputation in Patients with Diabetic Foot Ulcers Treated by Autologous Cell Therapy. J Diabetes Res. 2022;3954740. DOI: https://doi.org/10.1155/2022/3954740
Rehak L, Giurato L, Meloni M, et al. The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration — A Narrative Review. J Clin Med 2022;11:889. DOI: https://doi.org/10.3390/jcm11030889
Ragghianti B, Berardi BM, Mannucci E, Monami M. Autologous Peripheral Blood Mononuclear Cells in Patients with Small Artery Disease and Diabetic Foot Ulcers: efficacy, safety and economic evaluation. J Clin Med 2023;12. DOI: https://doi.org/10.20944/preprints202305.1171.v1

How to Cite

Crisci, M., Lepore, G., Feleppa, F., Crisci, A., & Flagiello, F. (2023). Cytomorphological analysis of liquid platelet-rich fibrin produced with the DUO fixed angle centrifuge (Process, France) for use in the regenerative therapy of skin ulcers. Italian Journal of Wound Care, 7(3). https://doi.org/10.4081/ijwc.2023.103

Similar Articles

<< < 1 2 

You may also start an advanced similarity search for this article.